Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,589 | 300,484 | 283,610 | 276,774 | 245,965 |
| Marketable Securities | 98,745 | 145,380 | 210,016 | 207,841 | 207,845 |
| Receivables | 115,268 | 114,367 | 104,745 | 113,304 | 100,653 |
| Inventories | 157,680 | 148,163 | 133,754 | 125,282 | 111,865 |
| TOTAL | $562,751 | $745,613 | $759,962 | $745,130 | $689,969 |
| Non-Current Assets | |||||
| PPE Net | 147,388 | 155,178 | 164,451 | 167,169 | 166,852 |
| Investments And Advances | 20,271 | 18,810 | 28,031 | 35,649 | 0 |
| Intangibles | 402,713 | 442,863 | 456,489 | 425,970 | 440,292 |
| Other Non-Current Assets | 164,454 | 174,798 | 177,736 | 179,598 | 224,578 |
| TOTAL | $734,826 | $791,649 | $826,707 | $808,386 | $831,722 |
| Total Assets | $1,297,577 | $1,537,262 | $1,586,669 | $1,553,516 | $1,521,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 202,397 | 202,086 | 201,776 | 201,466 |
| Accounts payable and accrued liabilities | 17,687 | 30,124 | 23,172 | 19,133 | 19,367 |
| Accrued Expenses | 79,643 | 71,023 | 80,069 | 80,124 | 76,377 |
| TOTAL | $107,078 | $313,164 | $314,732 | $309,920 | $306,401 |
| Non-Current Liabilities | |||||
| Long Term Debt | 376,721 | 97,828 | 101,489 | 383,545 | 107,024 |
| Other Non-Current Liabilities | 81,977 | 363,920 | 364,911 | 81,703 | 358,683 |
| TOTAL | $463,285 | $466,331 | $473,396 | $465,248 | $465,707 |
| Total Liabilities | $570,363 | $779,495 | $788,128 | $775,168 | $772,108 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,021 | 44,933 | 46,305 | 46,276 | 46,173 |
| Common Shares | 48 | 48 | 47 | 47 | 47 |
| Retained earnings | -200,959 | -206,391 | -201,544 | -206,356 | -222,397 |
| Other shareholders' equity | 4,580 | 4,547 | 1,230 | 222 | 557 |
| TOTAL | $727,214 | $757,767 | $798,541 | $778,348 | $749,583 |
| Total Liabilities And Equity | $1,297,577 | $1,537,262 | $1,586,669 | $1,553,516 | $1,521,691 |